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Abstract
The essential role of the lipophosphoglycan (LPG) of Leishmania in innate immune response has been extensively reported.
However, information about the role of the LPG-related glycoinositolphospholipids (GIPLs) is limited, especially with respect
to the New World species of Leishmania. GIPLs are low molecular weight molecules covering the parasite surface and are
similar to LPG in sharing a common lipid backbone and a glycan motif containing up to 7 sugars. Critical aspects of their
structure and functions are still obscure in the interaction with the vertebrate host. In this study, we evaluated the role of
those molecules in two medically important South American species Leishmania infantum and L. braziliensis, causative
agents of visceral (VL) and cutaneous Leishmaniasis (CL), respectively. GIPLs derived from both species did not induce NO or
TNF-a production by non-primed murine macrophages. Additionally, primed macrophages from mice (BALB/c, C57BL/6,
TLR22/2 and TLR42/2) exposed to GIPLs from both species, with exception to TNF-a, did not produce any of the
cytokines analyzed (IL1-b, IL-2, IL-4, IL-5, IL-10, IL-12p40, IFN-c) or p38 activation. GIPLs induced the production of TNF-a and
NO by C57BL/6 mice, primarily via TLR4. Pre incubation of macrophages with GIPLs reduced significantly the amount of NO
and IL-12 in the presence of IFN-c or lipopolysaccharide (LPS), which was more pronounced with L. braziliensis GIPLs. This
inhibition was reversed after PI-specific phospholipase C treatment. A structural analysis of the GIPLs showed that L.
infantum has manose rich GIPLs, suggestive of type I and Hybrid GIPLs while L. braziliensis has galactose rich GIPLs,
suggestive of Type II GIPLs. In conclusion, there are major differences in the structure and composition of GIPLs from L.
braziliensis and L. infantum. Also, GIPLs are important inhibitory molecules during the interaction with macrophages.
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Introduction
In the Americas, Leishmaniases are widely distributed from the
southern United States to northern parts of Argentina [1]. In Latin
America, especially in Brazil, Leishmania braziliensis and Leishmania
infantum are the causative agents of cutaneous (CL) and visceral
leishmaniasis (VL), respectively. The severity of the disease may
range from self-healing cutaneous ulcers to potentially lethal
visceral form [2].
During the life cycle, Leishmania parasites have to survive to
extreme adverse conditions in both vertebrate and invertebrate
hosts [3]. In the vertebrate host, inoculation of metacyclic
Leishmania promastigotes by the sand fly is followed by neutrophil
phagocytosis prior to intracellular differentiation into amastigotes
[4]. At the early steps of infection, innate cellular microbicidal
mechanisms may include the production of reactive nitrogen
intermediates (RNI), reactive oxygen intermediates (ROI) and
cytokines (IL-12, TNF-a and IFN-c) [5,6]. This is crucial for Th1
polarization and subsequent parasite control in the mouse model.
Failure in this process can lead to higher parasite burden and
increase severity of disease [7].
To avoid destruction, intracellular parasites must interfere with
the cytocidal signaling system of the host. In vivo and in vitro studies
have demonstrated the importance of nitric oxide (NO) production
in response to several stimuli such as bacterial lipopolysaccharide
(LPS), IFN-c and TNF-a [8]. It is known that Leishmania-infected
macrophages fail to activate MAPKs, become less responsive to
cytokine stimulation (IL-12 and IFN-c) [9,10,11] and express
lower amounts of iNOS and IL-12 [12,13], impairing T CD4+ cell
differentiation to a TH1 phenotype.
The molecular mechanisms involved in the immune system
modulation by Leishmania have been the focus of many studies.
GPI-anchored molecules are closely associated with cell signaling
and can act as agonists and second messengers in response to
cytokines and other stimuli [9,14,15,16]. The most studied
Leishmania glycoconjugate is lipophosphoglycan (LPG), whose
functions include: attachment and entry into macrophages [17],
modulation of NO production [18], inhibition of protein kinase C
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(PKC) dependent cell activation [19,20], retardation of phago-
some maturation [21], disruption of NADPH oxidase assembly at
the phagosome membrane [22], induction of neutrophil extracel-
lular traps (NETs) [23], induction of protein kinase R (PKR) [24],
and attachment to the sand fly vector midgut [25]. In Leishmania,
Toll-like receptor 2 (TLR2) is the main receptor for both LPG and
glycoinositolphospholipids (GIPLs), the latter as a less potent
agonist [26,27]. Besides TLR2, in vivo studies have also
demonstrated the importance of TLR4 and TLR9 during
Leishmania infection [28,29,30].
Little is known about the functions of GIPLs in Leishmania
biology, although they are present as the major component of the
parasite surface in numbers greater than LPG [31]. The basic
GIPL structure is a Mana1-4GlcN linked to an alkyl-acylglycerol
through a phosphatidylinositol (PI) residue. Polymorphism in this
family of molecules relies on the variety of fatty acid substitutions
in the lipid anchor and monosaccharide substitutions in the glycan
core moiety, leading to their classification into three groups
(Figure 1): Type-I GIPLs are characterized by having an a1,6-
mannose residue linked to the Mana1-4GlcN motif. This group is
represented by M2 and M3 GIPLs which structures are Mana1-
6Mana1-4GlcN-PI and Mana1-2 Mana1-6Mana1-4GlcN-PI.
Type I GIPLs are closely related to GPI anchors of proteins with
a very homogeneous lipid composition, predominantly C18:0 fatty
acids, and are found in Old World species such as L. donovani, L.
tropica and L. aethiopica promastigotes [32]. Type-II GIPLs have a
much more heterogeneous lipid composition with C18:0, C22:0,
C24:0 and C26:0 fatty acids. They can be found in Old World L.
major [33,34] and New World L. mexicana [35,36] and L. panamensis
[36]. Type II GIPLs are characterized by having an a1,3-mannose
residue linked to the Mana1-4GlcN motif, similarly to the glycan
core of LPG. Structurally, they can range from small iM2 GIPL,
Mana1-3Mana1-4GlcN-PI, to longer structures like GIPL-A,
Galfb1-3Gala1-3Galfb1-3Mana1-3Mana1-4GlcN-PI and GIPL-
3, Gala1-6Gala1-3Galfb1-3Mana1-3Mana1-4GlcN-PI. The third
group is the Hybrid-type GIPLs, sharing common features to both
Type-I and II with mannose residues located on both C-3 and C-6
positions of the Mana1-4GlcN motif (isoM3 and isoM4). There
may be also other substitutions like phosphate sugars and
ethanolamine residues [35,37]. Early studies have shown that
GIPLs from L. major were highly antigenic, being recognized by
sera from chronic CL patients [38]. Recent findings have
demonstrated that L. braziliensis GIPLs are components of complex
membrane microdomains and that these structures were crucial
for parasite infectivity and survival [39]. However, little is known
about the role of GIPLs in the innate immune compartment,
especially in L. braziliensis and L. infantum.
This work is part of a wider study on the glycobiology of New
World species of Leishmania. In previous studies, we reported on the
LPGs of L. braziliensis and L. infantum [40,41] and showed that the
differences in LPG structures were relevant in the parasite biology.
In this study, we expanded those findings and show the GIPL
structures of the two New World Leishmanias also differentially
modulate the innate immune system in mouse peritoneal
macrophages.
Materials and Methods
All animals were handled in strict accordance with good animal
practice as defined by the Internal Ethics Committee in Animal
Experimentation (CEUA) of Fundac¸a˜o Oswaldo Cruz (FIO-
CRUZ), Belo Horizonte (BH), Minas Gerais (MG), Brazil
(Protocol P-0297-06). Knock-out mice handling protocol was
approved by the National Commission of Biosafety (CTNBio)
(protocol #01200.006193/2001-16).
Parasites
World Health Reference strains of L. braziliensis (MHOM/BR/
1975/M2903), L. infantum (MHOM/BR/1974/PP75) and L.
donovani (MHOM/SD/00/1S-2D) were used. Promastigotes were
cultured in M199 medium supplemented with 10% heat-
inactivated fetal bovine serum (FBS), penicillin 100 units/ml,
streptomycin 50 mg/ml, 12.5 mM glutamine, 0.1 M adenine,
0.0005% hemin, and 40 mM Hepes, pH 7.4 at 26uC [40].
Extraction and purification of GIPLs
Cells were harvested and washed in PBS twice prior to GIPLs
extraction with methanol:chloroform:water (10:10:3). This mate-
rial was dried under nitrogen stream, resuspended on 0.1 M
ammonium acetate buffer containing 5% 1-propanol and loaded
onto an octyl-sepharose column (80 ml) equilibrated in the same
buffer. The column was subjected to a gradient of 1-propanol in
0.1 M ammonium acetate buffer (5–60%). Three mL fractions
were collected and the presence of GIPLs in the fractions was
detected by staining aliquots of the fractions on a TLC plate with
orcinol:sulfuric acid (100uC, 5 min) [34]. GIPLs containing
fractions were pooled, dried and resuspended in endotoxin-free
water (Sanobiol, Sa˜o Paulo, Brazil). GIPLs concentrations
determined as described elsewhere [42]. Prior to use on in vitro
macrophage cultures, GIPLs were diluted in fresh RPMI.
Purification of murine peritoneal macrophages and cell
culture
Thioglycollate-elicited peritoneal macrophages were removed
from BALB/c, C57BL/6 and respective TLR22/2 and
TLR42/2 knockouts by peritoneal washing with RPMI and
enriched by plastic adherence for 18 h. Cells (36105 cells/well)
were cultured in RPMI, 2 mM glutamine, 50 U/ml of penicillin
and 50 mg/mL streptomycin in 96-well culture plates (37uC/5%
CO2). They were incubated with gamma interferon (IFN-c)
(100 IU/mL) [43], live stationary Leishmania parasites (10:1),
GIPLs (1, 5, 10 and 25 mg/mL) and lipopolysaccharide (LPS)
(100 ng/mL).
Cytokine and nitrite measurements
For CBA multiplex cytokine detection, cells were plated as
described above for 1 h before washing with RMPI without
Author Summary
Leishmania infantum (syn. L. chagasi) and L. braziliensis are
the causative agents of VL and CL, respectively, in the New
World. A vital part of the parasite’s life cycle involves the
circumvention of the host immune system and the
infection of macrophages. This work focused on an
important class of surface glycoconjugates, the glycoino-
sitolphospholipids (GIPLs), and their role in the interaction
with murine macrophages. GIPLs are expressed on every
stage of the parasite life cycle and are the most abundant
molecules on its surface. Here we show that these
molecules modulate many macrophage functions such as
cytokine production, release of nitric oxide and differen-
tially activate MAPK. Although the GIPLs of both New
World species are capable of modulating the same
mechanisms, they do so to different degrees requiring
an examination of their glycan composition. We show that
L. infantum synthesize mannose rich GIPLs whereas L.
braziliensis express galactose rich GIPLs.
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serum. RPMI supplemented with 10% FBS was added with (for
primed macrophages) or without (for non-primed macrophages)
the addition of IFN-c (3 IU/mL) [44] and incubated for 18 h
(37uC, 5% CO2). GIPLs (25 mg/mL) and LPS (100 ng/mL) were
added and incubated for 48 h. Supernatants were collected and
stored at 270uC and cytokines (IL1-b, IL-2, IL-4, IL-5, IL-10, IL-
12p40, IFN-c and TNF-a) were determined using the BD CBA
Mouse Cytokine assay kits according to the manufacturer’s
specifications (BD Biosciences, CA, USA). Flow cytometric
measurements were performed on a FACS Calibur flow cytometer
(Becton Dickinson, Mountain View, CA). Cell-QuestTM software
package provided by the manufacturer was used for data
acquisition and the FlowJo software 7.6.4 (Tree Star Inc., Ashland,
OR, USA) was used for data analysis. A total of 1,800 events were
acquired for each preparation. Results are representative of two
experiments in duplicate.
For inhibition studies, cell suspensions were washed with
RPMI and enriched by plastic adherence for 18 h as described
above without the addition of IFN-c. Cells were pre-incubated
with GIPLs (15 min) prior to stimulation with LPS or IFN-c.
Supernatants were collected after 24 h for NO, TNF-a and IL-
12 measurements. When used, LPS or IFN-c were added 15 min
after the addition of GIPLs. Culture supernatants were collected
and nitrite concentrations determined by Griess reaction [45]
and TNF-a and IL-12 concentrations were determined using
ELISA (BD). Results are representative of two experiments in
triplicate.
PI-specific phospholipase-C treatment (PI-PLC)
To evaluate whether intact GIPL structure is required for
activity. Purified GIPLs were ressuspended in 150 ml CHAPS
buffer (298 mg HEPES, 47 mg EDTA and 50 mg CHAPS in
50 ml endotoxin-free water) and 2 U of PI-PLC (Sigma) (37uC,
16 h). Peritoneal macrophages were plated and stimulated with
intact and PI-PLC treated GIPLs as described above. Nitrite
content was measured on the supernatants by Griess reaction [45].
Figure 1. Types of GIPLs. For information on M2, M3, iM2, GIPL-A, isoM3 and isoM4, see introduction. Fatty acid chains vary in different GIPL
species: The predominant type fatty acid in Type-1 and Hybrid GIPLs is C18:0, in type-2 GIPLs the predominant lipids are C18:0, C22:0 C24:0 and C26:0. ‘‘R’’
in Type 1 GIPLs represent a protein linked to the GIPL structure by a ethanolamine phosphate residue (e.g. gp63 surface metalloprotease) [31,78].
doi:10.1371/journal.pntd.0001543.g001
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Preparation of cell lysates and immunoblotting
Stimulated cells (36106/sample) were washed with ice-cold
PBS, lysed in lysis buffer (20 mM Tris-HCl pH 7.5, 1% Triton
X-100, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfo-
nyl fluoride (PMSF), 50 mM sodium fluoride, 150 mM NaCl,
5 mM ethylenediamine tetraacetic acid (EDTA), 10% Glycerol
(v/v), 0.5 mM dithiothreitol (DTT) and protease inhibitor
cocktail from SigmaH). Cells were harvested with a plastic
scraper and centrifuged at 13,0006g (4uC, 10 min). Supernatants
were transferred to fresh tubes and stored at 220uC until used.
Cell lysates were resolved by SDS-PAGE, transferred to a
nitrocellulose membrane and blocked (5% milk in TBS-0.1%
Tween 20) for 1 h. Primary Abs (anti dually phosphorylated
ERK, dually phosphorylated p38 and Total ERK, 1:1,000) were
incubated for 16 h at 4uC. Membranes were washed (3610 min)
with TBS-0.1% Tween 20 and incubated 1 h with anti-mouse
IgG conjugated with peroxidase (1:10,000). The reaction was
visualized using luminol.
Nitrous acid deamination
Purified GIPLs were delipidated by nitrous acid deamination
(300 ml of 0.5 M sodium acetate and 300 ml of 0.5 M NaNO2)
for 16 h at 37uC [40]. Samples were dried, resuspended in
0.1N HAc/01M HCl and applied to a phenyl-sepharose column
(1 mL). The sugar headgroups were eluted using 0.1N HAc/
0.1M HCl. After washing column with 2 volumes of water,
lipids and unreacted GIPLs were eluted using Solvent E
(H2O/ethanol/diethyl ether/pyridine/NH4OH; 15:15:5:1:0.017)
[46].
Gel filtration
To desalt, deaminated GIPLs glycan headgroups were applied
to Sephadex G-25 (165 cm) columns equilibrated with 10 ml of
water. Eluted deaminated glycan headgroups were collected in
0.5 ml fractions, checked for the presence of salt using silver
nitrate and dried in Speed-Vac [40].
Strong acid hydrolysis
To obtain depolymerized neutral monosaccharides, deaminated
glycan headgroups were subjected to strong acid hydrolysis (2N
trifluoracetic acid, 3 h, 100uC) and dried in Speed-Vac. To
remove acid, 500 ml of toluene were added to samples,
homogenized using vortex and evaporated twice under N2.
Samples were resuspended in 500 ml of water and desalted by
ion exchanging chromatography.
Ion exchange chromatography
To remove salt from neutral monosaccharides, dried depoly-
merized neutral monosaccharides were diluted in 500 ml of H2O
and applied onto a column containing AG1-X8 acetate form over
AG50W-X12 resins. Samples were eluted with 5 mL of water and
dried in a Speed-Vac instrument [47].
Thin layer chromatography (TLC)
Intact and deaminated GIPLs were chromatographed on TLC
Silica Gel 60 plates (Merck). To compare rough GIPL content of
L. braziliensis, L. infantum and as reference L. donovani. Intact GIPLs
were chromatographed in 1-butanol:methanol:water (4:4:3 v/v)
for 20 h. To access Deamination by nitrous acid sensitivity, GIPLs
were subjected to nitrous acid deamination as described above and
resolved in chloroform:methanol:13M ammonium hydroxide:1M
ammonium acetate:water (180:140:9:9:23 v/v) for 20 h. Bands
were visualized as described above [46,48].
Fluorophore-assisted carbohydrate electrophoresis
(FACE)
To access the oligosaccharide composition, deaminated GIPLs
headgroups were fluorescently labeled with 0.05 N ANTS (8-
aminonaphthalene-1,3,6-trisulfate) and 1 M cyanoborohydride
(37uC, 16 h). To determine the monosaccharide composition of
the GIPLs, depolymerized and desalted monosaccharides were
fluorescently labeled with 0.1 M AMAC (2-aminoacridone) in
5% acetic acid and 1 M cyanoborohydride. Labeled sugars were
subjected to FACE and the gel was visualized under UV light.
Oligoglucose ladders (G1–G7) and monosaccharides (D-galac-
tose, D-glucose and D-mannose) (Sigma) were used as standards
for oligosaccharides and monosaccharide gels, respectively
[47,49].
HPLC
Desalted monosaccharides were separated using a DX-500
HPLC (Dionex Corp.) with ED40 electrochemical detection.
Samples were run on a CarboPac PA10 column (46250 mm) in
the presence of 18 mM NaOH (flow rate 1 mL/min, 2000 psi). D-
galactose, D-glucose and D-mannose (100 mg/mL) were used as
standards.
Statistical analyses
For nitrite and cytokine measurements, the Shapiro–Wilk test
was conducted to test the null hypothesis that data were sampled
from a Gaussian distribution [50]. The P value (P.0.05) showed
that data did not deviate from Gaussian distribution. For this
reason, student’s ‘‘t’’ test and ANOVA were performed to test
equality of population medians among groups and independent
samples. Data were analysed using GraphPad Prism 5.0 software
(Graph Prism Inc., San Diego, CA) and P,0.05 was considered
significant.
Results
Nitrite and cytokine production
To determine whether GIPLs from both L. braziliensis and L.
infantum are able to induce the production of nitrite, peritoneal
macrophages were incubated with live promastigotes (10:1) or
treated with different concentrations of GIPLs (1 to 25 mg/mL)
with IFN-c serving as positive control (100 IU/mL). Neither of the
purified GIPLs could induce any detectable increase in the
production of nitric oxide (NO) in primed BALB/c macrophages
(Figure 2) nor the production of the cytokines tested (IL1-b, IL-2,
IL-4, IL-5, IL-10, IL-12p40, IFN-c and TNF-a) in non-primed
macrophages in all other mice lineages (data not shown). No NO
production was detected in non-primed macrophages of BALB/c,
C57BL/6, TLR22/2 and TLR42/2 mice (data not shown) and
in BALB/c primed macrophages (Figure 3A). A higher NO
production was detected on C57BL/6 IFN-c-primed macrophages
stimulated with GIPLs and live promastigostes when compared to
BALB/c mice (P,0.001). There was a significant NO production
in primed C57BL/6 and TLR2 (2/2) macrophages stimulated
with GIPLs in comparison to TLR4 (2/2) (P,0.01) (Figure 3A)
suggesting the involvement of TLR4 in this activation. Also, a
slight reduction of NO production was noticed in macrophages
from TLR2 (2/2) mice stimulated with live promastigotes when
compared to C57BL/6 (P,0.04). This reduction may indicate the
participation of other parasite molecules that are recognized by
TLR2 such as the LPG. The LPG is known to be a potent agonist
of TLR2 and is capable of inducing the production of cytokines
(IL-12, IFN-c and TNF-a) in macrophages and NK cells [26,27].
Differently from NO, TNF-a production was higher in BALB/c
Leishmania GIPLs and Interaction with Macrophages
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mice than in C57BL/6 (P,0.05) in response to the stimulation of
GIPLs from both species. Similarly this production was higher in
TLR2 (2/2) than TLR4 (2/2) (P,0.02). This data also indicate
a slight TLR4 involvement in TNF-a production. In both WT
macrophages, the TNF-a production was higher after stimulation
with GIPLs in comparison to live promastigotes (Figure 3B)
(P,0.01). A lower TNF-a production was noticed in TLR2 (2/2)
suggesting the involvement of TLR2 in this process.
GIPLs did not induce the production of any of the cytokines
tested (IL1-b, IL-2, IL-4, IL-5, IL-10, IL-12p40 and IFN-c) in
BALB/c, C57BL/6, TLR2 (2/2) and TLR4 (2/2) mice (data
not shown). In all experiments, live parasites from both species
induced cytokine production close to background levels (Figure 3B
and data not shown). These results suggest that GIPLs are able to
activate NO in C57BL/6 mice and TNF-a in either BALB/c or
C57BL/6 during the early steps of infection, and were not able to
stimulate most of the cytokines assayed.
Inhibition of nitrite and IL-12 production in BALB/c
macrophages pre-exposed to GIPLs
Compared to LPG, GIPLs had a less potent agonistic activity to
stimulate nitrite and cytokine production in previous studies [27].
To test if this pattern was due to inhibition and/or lack of
activation, thioglycollate elicited peritoneal macrophages were
pre-incubated with GIPLs prior to stimulation with IFN-c or LPS.
A strong inhibition (aprox. 42%) of NO production stimulated by
IFN-c was observed for L. infantum GIPLs and was almost
completely abolished for L. braziliensis (P,0.01) (Figure 4A). A
similar response was observed for LPS and this inhibition was
more pronounced in L. braziliensis (P,0.001) (Figure 4B). Pre-
incubation with GIPLs was also able to inhibit approximately 65%
of IL-12, but not TNF-a production (Figures 4C and D). These
results indicate an inhibitory role of GIPLs.
Figure 2. Nitrite production by BALB/c primed macrophages
after stimulation with different concentrations of GIPLs. C,
negative control; IFN-c, gamma-interferon; LPS, lipopolysaccharide; Gb,
L. braziliensis GIPLs; Gi, L. infantum GIPLs. Cells were primed with IFN-c
(3 IU/ml) for 18 h prior to the addition of the GIPLs or LPS (positive
control). Non primed cells and primed cells without the addition of a
new stimulus were also used as controls. ANOVA test was performed
and P,0.05 was considered significant. Results are the representation
of three experiments in triplicate.
doi:10.1371/journal.pntd.0001543.g002
Figure 3. Nitrite and TNF-a production by primed macrophages after stimulation with GIPLs and parasites. C, negative control; Gb, L.
braziliensis GIPLs; Gi, L. infantum GIPLs; Lb, L. braziliensis live promastigotes and Li, L. infantum live promastigotes. Cells were pre-incubated with IFN-c
(3 IU/ml) for 18 h then 25 mg/mL of GIPLs or 100 ng/mL of LPS was added. Supernatants were collected 48 hours later, in (A) NO concentrations were
measured by Griess reaction and in (B) TNF-a concentrations determined by flow cytometry. ANOVA test was performed and P,0.05 was considered
significant.
doi:10.1371/journal.pntd.0001543.g003
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Also, to test whether the intact structure of GIPLs is required for
its inhibitory activity Macrophages were incubated with intact and
PI-PLC treated GIPLs. As shown on Figure 5 PI-PLC treated
GIPLs failed to inhibit NO production by IFN-c stimulated cells.
Activation of MAPKs
Since GIPLs were strong inhibitors of cytokine production, we
investigated whether those molecules could modulate MAPKs
activation. Mouse peritoneal macrophages were previously
incubated with GIPLs and MAPK activation was detected using
western blot. No significant activation of p38 and only a minimal
induction of ERK were observed. Also when cells were
preincubated with GIPLs prior to stimulation with LPS, there
was a reduction on the phosphorylation of both ERK and p38
(Figure 6). Densitometer analysis normalized by total-ERK
expression detected an 18% and 17.5% decrease on ERK
activation for L. braziliensis and L. infantum, respectively. For p38
this inhibition was 16.5% and 33%, respectively.
Preliminary characterization of L. braziliensis and L.
infantum GIPLs
Due to the interspecific differences in the intensity of NO and
IL-12 production inhibition (Figures 4) and MAPKs activation
(Figure 6), we examined whether those variations could be due to
polymorphisms in GIPLs structure and composition. Intact GIPLs
were resolved on TLC plates and the GIPL profile differed
between the two species (Figure 7A). Leishmania braziliensis
exhibited slower migrating GIPLs compared to L. infantum, whose
Figure 4. Modulation of nitrite, TNF-a and IL-12 production by Leishmania GIPLs in BALB/c macrophages. Cells were incubated with
GIPLs (25 mg/ml) from L. braziliensis (Gb) and L. infantum (Gi) for 15 min prior to stimulation with IFN-c (100 IU/ml) (A) or LPS (100 ng/mL) (B). Nitrite
content was measured by Griess reaction; TNF-a and IL-12 concentrations were measured by ELISA. P,0.05 was considered significant. Results are
the representation of three experiments.
doi:10.1371/journal.pntd.0001543.g004
Figure 5. Modulation of nitrite production by macrophages
stimulated with intact and PI-PLC treated GIPLs. Mouse
peritoneal macrophages were incubated with GIPLs (25 mg/ml) from
L. braziliensis (Gb), L. infantum (Gi), PI-PLC treated L. braziliensis GIPLs
(Gb PI-PLC) and L. infantum PI-PLC treated GIPLs (Gi PI-PLC) for 15 min
prior to stimulation with IFN- c (100 IU/ml). Nitrite content was
measured by Griess reaction on the supernatants after 24 h. Student
‘‘t’’ test was performed and P,0.05 was considered significant. Results
are the mean of two experiments.
doi:10.1371/journal.pntd.0001543.g005
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profile was very similar to L. donovani [32] with three main bands
co-migrating with isoM2, isoM3 and isoM4. In L. braziliensis, the
three faster bands co-migrated with bands isoM2, isoM3 and
isoM4 of L. donovani. All bands were susceptible to nitrous acid
deamination, and this is consistent with the presence in the GIPLs
of a non-N-substituted glucosamine residue (Figure 7B), a
hallmark of Leishmania GIPLs anchors [51].
To better determine sizes of the glycan portions, purified GIPLs
were deaminated and desalted. The carbohydrate portions were
reductively labeled with a fluorphore and then subjected to FACE.
Consistent with the TLC data (Figure 7), the carbohydrate
portions of the GIPLs from L. braziliensis were larger exhibiting up
to 8–9 sugars while those from L. infantum and L. donovani consisted
of up to 4–5 sugars (Figure 8).
To access sugar composition, GIPLs were subjected to strong
acid hydrolysis and the resulting monosaccharides were analysed
by FACE and HPLC (Figure 9A and B). Consistent with the TLC
data (Figure 7A), the monosaccharide composition of L. infantum
GIPLs was very similar to the GIPLs from L. donovani (Figure 9A).
The relative amounts of galactose, glucose and mannose
(calculated by the relative peak areas on HPLC) were determined
(Figure 9B). Supporting our other findings and GIPL assignments,
the GIPLs from L. infantum had higher concentrations of mannose
(82%), followed by galactose (12%) and glucose (6%). This
indicates that these are mostly Type I or hybrid GIPLs, whose
structure bears a terminal mannose, but a small proportion of
Type II GIPLs (terminated in galactose) is probably present. On
the other hand, L. braziliensis GIPLs had higher galactose content
(42%), followed by, mannose (30%) and glucose (28%), thus
suggesting a Type II GIPL structure.
Discussion
Infection with protozoan parasites remains a prominent problem
in different parts of the world having a major impact on public
health in the developing countries. Leishmaniases are considered by
World Health Organization [52] as one of the major six important
infectious diseases worldwide. This class of parasitic diseases
currently affects over 12 million people all around the world, up
to 1.5 million new individuals developing the visceral and
tegumentar disease respectively each year. In Brazil, most of those
cases are caused by L. infantum and L. braziliensis, respectively.
The question of how parasites interact with hosts cells to
promote infection and survival has been the focus of interest for a
long time. In order to survive in the macrophage cells, Leishmania
has to prevent or inhibit a variety of intracellular mechanisms of
parasite killing, one of which is dependent on ROS and RNI
[53,54]. However, RNI alone is effective for controlling visceral
Leishmaniasis [55].
Parasite surface molecules, especially the LPG, have long been
known to play an important role in the host parasite interactions
[17,27,56]. In this work, we focused on another class of
glycoconjugates, the GIPLs in two New World species of
Leishmania with different known immunopathologies. These
molecules are abundantly present on the parasite surface in
Figure 6. Activation of MAPKs (ERK and p38) by Leishmania
GIPLs in BALB/c peritoneal macrophages. Mouse peritoneal
macrophages were stimulated for 30 min with 25 mg/mL of GIPLs.
Dually phosphorylated MAPKs were detected by western blot. C,
negative control; Gb, L. braziliensis GIPLs and Gi, L. infantum GIPLs. Also
cells were incubated with GIPLs prior to stimulation with LPS; total ERK
content as a normalizing protein.
doi:10.1371/journal.pntd.0001543.g006
Figure 7. Thin layer chromatography (TLC) of Leishmania glycoinositolphospholipids (GIPLs). (A) Purified intact GIPLs: Lane 1, L.
braziliensis GIPLs (Gb); lane 2, L. infantum GIPLs (Gi) and lane 3, L. donovani GIPLs (Gd). The assignments for L. donovani structures are: isoM2 as
Mana1-3Mana1-4GlcN-PI; isoM3 as Mana1-6(Mana1-3)Mana1-4GlcN-PI and isoM4 as Mana1-2Mana1-6(Mana1-3)Mana1-4GlcN-PI [32]. LPG,
lipophosphoglycan; GPI, glicosyl phosphatidylinositol. (B) Deaminated GIPLs. Lane 1, L. braziliensis untreated GIPLs (Gb); lane 2, deaminated L.
braziliensis GIPLs (Gb deam.); lane 3, L. infantum untreated GIPLs (Gi) and Lane 4, deaminated L. infantum GIPLs (Gi deam.).
doi:10.1371/journal.pntd.0001543.g007
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numbers great that 107. Recently, they have been found
associated to lipid rafts, essential for parasite infectivity and
selective modulation of the host cell response [39]. In fact, there
are several indications that GIPLs and other GPI-anchored
molecules participate in cell signaling and are involved in the
assembly of the NADPH oxidase complex, NO production
[16,57,58,59,60] and inhibition of LPS and TNF-a induced c-fos
gene expression by macrophages [61]. Also synthetic LPG, whose
GPI anchor is structurally similar to GIPLs, can stimulate ERK
activation and therefore inhibit IL-12 synthesis by macrophages
[9].
Previous studies have demonstrated GIPLs antigenicity in
chronic patients infected with L. major [38,62]. However,
information concerning the biological relevance of GIPLs at early
steps of infection in the innate immune compartment was still
limited. Here, we demonstrated that GIPLs from both New World
species were not able to activate the production of NO in non-
primed macrophages, which was similar to published data from
Old World species [59,60]. In primed macrophages an initial NO
and TNF-a production was detected. Further, GIPLs differentially
inhibited NO production even in the presence of IFN-c and LPS,
two major NO inducers. Previous studies indicated that LPG was
a more potent agonist than GIPLs for the induction of pro-
inflammatory cytokines [26,27]. In general, in comparison to LPS,
GIPLs induced a lower production of NO and TNF-a. Also, they
exhibited a strong inhibitor pattern during NO and cytokine
induction, especially IL-12.
Similar strategy was demonstrated using crude extracts of the
rat tapeworm Hymenolepis diminuta, although using different
pathways. As shown by Johnston et al. (2010) [63], crude extracts
of this tapeworm could inhibit the production of TNF-a and IL-6
by mouse and human macrophages stimulates with TLR agonists
poly(I:C) and Flagellin. These extracts also protected mice from
experimental colitis accompanied by enhanced IL-10 and IL-4
production.
In vivo studies using Old World species of Leishmania have
demonstrated the importance of TLRs and other components of
the innate immune system during infection. MyD88 is the most
common adaptor molecule for the activation of NF-kB in most
TLRs [28]. Also many studies using gene knockout have shown
the importance of TLR and MyD88 adaptor molecule for cytokine
production [29], IL-1 promoter activation [64], IFN-c and IL-12
production [65].
NF-kB activation through TLR2 [26], elastase dependent
neutrophil control of L. amazonensis promastigotes [66], and
ultimately parasite control and lesion healing [27,65,67].
Indeed, in primed macrophages, GIPLs from both New World
species were able to stimulate the production of NO, and this
induction was mostly via TLR4 and to a lesser extent TLR2
(Figure 3A). However, no difference was observed while
stimulating with live parasites.
Interestingly, in the L. braziliensis model, the TLR2 receptor
plays a much more regulatory role in dendritic cells, repressing IL-
12p40 and promoting IL-10 expression. This observation is
correlated with sustained IFN-c production and enhanced parasite
control in TLR2 (2/2) mice [68]. However, in macrophages
exposed to GIPLs, this difference in NO expression between
TLR2 (2/2) and TLR4 (2/2) strains was not due to IL-12, IFN-
c or IL-10 production (Figures 3B and 4). Also this induction was
more pronounced in C57BL/6 than in BALB/c this was expected
since C57BL/6 derived macrophages tend to be more responsive
to stimuli than BALB/c macrophages [69]. These data are in
accord with previous studies showing that related GIPLs from
Trypanosoma cruzi are able to activate TLR4 [70] and studies with
Figure 8. Fluorophore-assisted carbohydrate electrophoresis
(FACE) of Leishmania GIPLs. Lane 1, oligoglucose ladder represented
by G2-G7; lane 2, L. braziliensis GIPLs (Gb) and lane 3, L. infantum GIPLs
(Gi) and lane 4, L. donovani GIPLs (Gd).
doi:10.1371/journal.pntd.0001543.g008
Figure 9. Monosaccharide profile of Leishmania glycoinositol-
phospholipids (GIPLs). (A) Fluorophore-assisted carbohydrate elec-
trophoresis (FACE). Lane 1, standards represented by galactose, glucose
and mannose (100 mg/ml); lane 2, L. braziliensis GIPLs (Gb); lane 3, L.
infantum GIPLs (Gi) and Lane 4, L. donovani GIPLs (Gd). (B) High
performance liquid chromatography (HPLC). Gal, galactose; Glc, glucose
and Man, mannose.
doi:10.1371/journal.pntd.0001543.g009
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Old World species of Leishmania being able to activate TLR2,
TLR3, TLR4 and TLR9 [28]. With exception to TNF-a, GIPLs
and live parasites from L. braziliensis and L. infantum were not able
to induce the other cytokines studied (IL-1b, IL-2, IL-4, IL-5, IL-
10, IL-12p40 and IFN-c) in primed and non-primed macrophages
(data not shown). Thus, we conclude that the GIPLs from these
two New World species are less potent agonists or strong inhibitors
for macrophages and the data presented here supports that the
later might be true.
When pre incubated with GIPLs, a strong inhibition of both
NO and IL-12 production was observed (Figures 4C and D). This
inhibitory effect seems to be in specific pathways since no
significant inhibition was detected for TNF-a (Figure 4C). This
inhibition is dependent on the intact structure of GIPLs since PI-
PLC digested GIPLs that have its glycan core detached from its
lipid anchor, failed to inhibit NO production by IFN-c stimulated
macrophages (Figure 5). Also, regarding TNF-a, only WT mice
were able to trigger the production of this cytokine and this
production was very low for TLR2 (2/2) and completely absent
in TLR4 (2/2) (Figure 3B). These data supports the premise that
NF-kB translocation is not affected by GIPLs exposure [71]. It is
noteworthy that the inhibition of IL-12 is not due to production of
IL-10, because we observed no IL-10 production either in
unprimed (data not shown) or in primed macrophages incubated
with GIPLs (Data not shown).
In TLR signaling, the most common adaptor molecule is
MyD88 but other adaptor molecules may be involved in NF-kB
translocation such as mitogen-activated protein kinases (JNK or
p38) [72]. Early studies showed that the Leishmania LPG can inhibit
IL-12 without affecting NF-kB translocation to the nucleus [9].
For maximal downstream activation and GPI-induced gene
expression, a full activation and cooperation Protein Tyrosine
Kinase (PTK) and Protein Kinase C (PKC) are required. Although
iM4 L. mexicana GIPL stimulated rapid PTK phosphorylation it
failed in activating PKC [16]. In fact the unusual glycolipid
composition (mostly alkyl-acyl-glycerol) of Leishmania GIPLs
inhibits the activations of PKC [58,73]. This is in accordance
with our observations that GIPLs not only fail on inducing a pro-
inflammatory response in non-macrophages but also that the
GIPLs inhibit the productions of IL-12 and NO.
Also we tested whether GIPLs from both New World species
were able modulate the phosphorylation of MAPKs. We observed
that the GIPLs activate only ERK, whereas LPS activated both
ERK and p38 (Figure 6). Also we observed that the GIPLs can
prevent the phosphorylation of both ERK and p38 MAPKs
stimulated by LPS. However, ERK activation was too low to
provide evidence for any further effect on IL-12 production. It is
likely that L. braziliensis and L. infantum GIPLs have a profound
effect on macrophage cell signaling affecting PTKs, PKCs and
MAPKs, and that GIPLs from both species use similar pathways
but differ in the intensity in which they modulate NO and IL-12
production.
In this work, GIPLs interacted with primed macrophages
resulting only in the production of NO and TNF-a. GIPLs are
abundant in the amastigote stage of Leishmania and are associated
to highly specialized microdomains [39] and the participation of
each kind of GIPL on the process is still under debate [74,75,76].
Also it is possible that the dependency on a particular glycolipid
may vary throughout species and life cycle stage. The data
presented here clearly supports the hypothesis that Leishmania
GIPLs, differently from other trypanosomatids, may contribute to
build a safer environment to promote infection by manipulating
macrophage function and by disrupting the polarization of TH1/
TH2 response, through inhibiting IL-12 production during the
initial stages of infection and manipulate macrophage for parasite
survival.
In general, LPGs and GIPLs share similar lipid anchor moieties
among the various species of Leishmania and the integrity of this
portion is important for TLR2 activation [27]. To ascertain if the
differences in the inhibition of NO and IL-12 production could be
related to polymorphisms in GIPL structure, we analyzed the
carbohydrate core of L. braziliensis and L. infantum GIPLs. Previous
studies from our group showed that the phosphoglycan domains of
LPGs from L. braziliensis and L. infantum differ in structure and
composition [40,41] and differences in glycan portions of GIPLs
were also observed in this study. The iM2 species of GIPLs
possesses the structure Mana1-3Mana1-4GlcN-P) similar to LPG
core region, and isoM3 has a hybrid glycan in GIPLs (substitutions
on both the third and sixth carbons of the distal mannose) with the
structure of Mana1-6(Mana1-3Mana1-4GlcN-PI. Our structural
observations indicated that the GIPLs from L. infantum are similar
to the known structures in L. donovani [32] and are composed
mainly of mannose residues. This data suggests that the majority of
these GIPLs as Type I GIPLs and Hybrid GIPLs. On the other
hand, L. braziliensis GIPLs shows a different profile of sugar
composition and different bands distinguishable on TLC
(Figure 7A). We determined that there was a stoichiometric ratio
of galactose and mannose in the glycan portion of these GIPLs.
This data suggest that these GIPLs are similar to the closely related
species L. panamensis [36], which have a common Galfb1-3Mana1-
3Mana1-4GlcN-myoinositol glycan headgroup and a structurally
related to LPG lipid anchor, suggestive of Type II GIPLs. Type II
GIPLs can be very diverse and substitutions on the 3rd carbon of
the Galf residue by Gala-1, Gala1-3gala1, and even longer
saccharides like Mana1-PO4-6Gala1-6Gala1 can be detected in
other species like L. major [31]. These substitutions can lead to
large GIPLs containing up to 7, 8 or even more hexoses [34,36],
which we observed from the L. braziliensis GIPLs as seen on
Figure 8.
In conclusion, GIPLs from both New World species L. infantum
and L. braziliensis have a strong inhibitory potential during
intracellular Leishmania infection of the mammalian host. Only
an initial production of NO and TNF-a was detected after
stimulation by GIPLs. Due to their importance in modulating NO
and cytokine production, these molecules could be possible targets
to alternative immunological and chemotherapeutic control
methods. The preliminary qualitative analysis of GIPLs from
these two species showed that they differ in composition and
structures thus, suggesting that the structural distinctions could be
responsible for differential NO and IL-12 inhibition in macro-
phages. Also, GIPLs were also capable of affecting macrophage
ability to produce NO in the presence of IFN-c and LPS. These
data, together with already published data from other groups,
suggest that GIPLs may be involved in the interaction with the
macrophage triggering a minimal pro-inflammatory response in
the host and to the benefit of the parasite. Glycoconjugate
interspecies polymorphisms, not only in the GIPLs, but also in
LPG, gp63 and other GPI-anchored molecules could be important
for differential establishment of infection. These polymorphisms
could result in different clinical outcomes, such as those shown by
L. infantum and L. braziliensis, causative agents of a visceral and
tegumentary forms, respectively [77].
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